Long Term Evaluation of the Effect of Botulinum Toxin A Injection on the Masseteric |
Hong, Hee-Suk
(Dept. of Oral Medicine, College of Dentistry, Yonsei University)
Kang, Seung-Chul (Dept. of Oral Medicine, College of Dentistry, Yonsei University) Kim, Chong-Youl (Dept. of Oral Medicine, College of Dentistry, Yonsei University) Kim, Seong-Taek (Dept. of Oral Medicine, College of Dentistry, Yonsei University) |
1 | Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990;40(2):277-280 DOI |
2 | Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994;32(1):26-28 DOI ScienceOn |
3 | Freund B, Schwartz M, Symington JM. The use of botulinum toxin for the treatment of temporomandibular disorder: preliminary findings. J Oral Maxillofac Surg 1999;57(8):916-920 DOI PUBMED ScienceOn |
4 | Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137-139 DOI ScienceOn |
5 | Kim HJ, Yum KW, Lee SS, Heo MS, Seo K. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomograpic management. Dermatol Surg 2003;29(5):484-489 DOI ScienceOn |
6 | 장희영. 전산화 단층촬영으로 평가한 교근에 대한 보툴리눔 A 형 독소주사와 교합안정장치의 효과. 연세대학교 치의학과 박사논문, 2004 |
7 | Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9(1):31-39 DOI ScienceOn |
8 | Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol soc 1981;79:734-770 |
9 | To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200 DOI ScienceOn |
10 | von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-332 DOI ScienceOn |
11 | Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, Sudhof TC, Jahn R, Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 1994;269(3):1617-1620 |
12 | Legg JW. Enlargement of the temporal and masseter muscles on both sides. Trans Pathol Soc Lond 1880;31:361 |
13 | Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32(1):29-33 DOI ScienceOn |
14 | Ivanhoe CB, Lai JM, Francisco GE. Bruxim after brain injury: Successful treatment with botulinum toxin-A. Arch Phys Med Rehabil 1997;78:1272-1273 DOI ScienceOn |
15 | Niamtu J 3rd. Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg 1999;57(10):1228-1233 DOI PUBMED ScienceOn |
16 | Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A(BOTOX) for treatment of migraine headaches; an open-label study. Otolaryngol Head Neck Surg 2000;123(6):669-676 DOI PUBMED ScienceOn |
17 | Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003;29(5):477-483 DOI ScienceOn |
18 | Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 2002;27(11): 552-558 DOI PUBMED ScienceOn |
19 | Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migrane preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000;40(6):445-450 DOI ScienceOn |
20 | Pidcock FS, Wise JM, Christensen JR. Treatment of severe post-traumatic bruxism with botulinum toxin-A: Case report. J Oral Maxillofac Surg 2002;60:115-117 DOI ScienceOn |